Evaluation of the scalene lymph nodes in primary and recurrent cervical carcinoma

Thomas W. Burke, Paul Heller, William J. Hoskins, Edward B. Weiser, John D. Nash, Robert C. Park

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Open biopsy of the left scalene lymph nodes has been utilized to identify distant spread of cervical carcinoma in selected groups of patients who do not have other clinical evidence of disseminated disease. Twenty-one patients with primary cervical carcinoma and histologically proven para-aortic lymph node metastases and 10 patients with centrally recurrent tumors underwent scalene lymph node biopsy at Walter Reed Army Medical Center or the Naval Hospital, Bethesda, Maryland, between July 1, 1979 and June 30, 1985. All patients undergoing scalene node biopsy had clinically negative physical examinations. There were no surgical complications. All 31 biopsies were negative for metastatic tumor. Combined with previously reported data from this instituton, 3 of 28 patients (11%) with primary cervical carcinoma and involved para-aortic nodes, and 6 of 35 patients (17%) with centrally recurrent disease had subclinical scalene node metastases. Patients with clinically suspicious scalene lymphadenopathy had fine needle aspiration cytology performed to document metastatic disease. The success of this technique has eliminated the need for open biopsy in these patients. Scalene node biopsy provides valuable prognostic information in patients with cervical cancer who have positive para-aortic lymph nodes. It also obviates surgical exploration in some patients felt to have resectable recurrent disease who actually have subclinical distant spread.

Original languageEnglish (US)
Pages (from-to)312-317
Number of pages6
JournalGynecologic Oncology
Volume28
Issue number3
DOIs
StatePublished - Jan 1 1987
Externally publishedYes

Fingerprint

Lymph Nodes
Carcinoma
Biopsy
Neoplasm Metastasis
Fine Needle Biopsy
Uterine Cervical Neoplasms
Physical Examination
Cell Biology
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Obstetrics and Gynecology

Cite this

Burke, Thomas W. ; Heller, Paul ; Hoskins, William J. ; Weiser, Edward B. ; Nash, John D. ; Park, Robert C. / Evaluation of the scalene lymph nodes in primary and recurrent cervical carcinoma. In: Gynecologic Oncology. 1987 ; Vol. 28, No. 3. pp. 312-317.
@article{7be14038eee54b6a99d1b73cb9f6bab2,
title = "Evaluation of the scalene lymph nodes in primary and recurrent cervical carcinoma",
abstract = "Open biopsy of the left scalene lymph nodes has been utilized to identify distant spread of cervical carcinoma in selected groups of patients who do not have other clinical evidence of disseminated disease. Twenty-one patients with primary cervical carcinoma and histologically proven para-aortic lymph node metastases and 10 patients with centrally recurrent tumors underwent scalene lymph node biopsy at Walter Reed Army Medical Center or the Naval Hospital, Bethesda, Maryland, between July 1, 1979 and June 30, 1985. All patients undergoing scalene node biopsy had clinically negative physical examinations. There were no surgical complications. All 31 biopsies were negative for metastatic tumor. Combined with previously reported data from this instituton, 3 of 28 patients (11{\%}) with primary cervical carcinoma and involved para-aortic nodes, and 6 of 35 patients (17{\%}) with centrally recurrent disease had subclinical scalene node metastases. Patients with clinically suspicious scalene lymphadenopathy had fine needle aspiration cytology performed to document metastatic disease. The success of this technique has eliminated the need for open biopsy in these patients. Scalene node biopsy provides valuable prognostic information in patients with cervical cancer who have positive para-aortic lymph nodes. It also obviates surgical exploration in some patients felt to have resectable recurrent disease who actually have subclinical distant spread.",
author = "Burke, {Thomas W.} and Paul Heller and Hoskins, {William J.} and Weiser, {Edward B.} and Nash, {John D.} and Park, {Robert C.}",
year = "1987",
month = "1",
day = "1",
doi = "10.1016/0090-8258(87)90178-8",
language = "English (US)",
volume = "28",
pages = "312--317",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "3",

}

Evaluation of the scalene lymph nodes in primary and recurrent cervical carcinoma. / Burke, Thomas W.; Heller, Paul; Hoskins, William J.; Weiser, Edward B.; Nash, John D.; Park, Robert C.

In: Gynecologic Oncology, Vol. 28, No. 3, 01.01.1987, p. 312-317.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of the scalene lymph nodes in primary and recurrent cervical carcinoma

AU - Burke, Thomas W.

AU - Heller, Paul

AU - Hoskins, William J.

AU - Weiser, Edward B.

AU - Nash, John D.

AU - Park, Robert C.

PY - 1987/1/1

Y1 - 1987/1/1

N2 - Open biopsy of the left scalene lymph nodes has been utilized to identify distant spread of cervical carcinoma in selected groups of patients who do not have other clinical evidence of disseminated disease. Twenty-one patients with primary cervical carcinoma and histologically proven para-aortic lymph node metastases and 10 patients with centrally recurrent tumors underwent scalene lymph node biopsy at Walter Reed Army Medical Center or the Naval Hospital, Bethesda, Maryland, between July 1, 1979 and June 30, 1985. All patients undergoing scalene node biopsy had clinically negative physical examinations. There were no surgical complications. All 31 biopsies were negative for metastatic tumor. Combined with previously reported data from this instituton, 3 of 28 patients (11%) with primary cervical carcinoma and involved para-aortic nodes, and 6 of 35 patients (17%) with centrally recurrent disease had subclinical scalene node metastases. Patients with clinically suspicious scalene lymphadenopathy had fine needle aspiration cytology performed to document metastatic disease. The success of this technique has eliminated the need for open biopsy in these patients. Scalene node biopsy provides valuable prognostic information in patients with cervical cancer who have positive para-aortic lymph nodes. It also obviates surgical exploration in some patients felt to have resectable recurrent disease who actually have subclinical distant spread.

AB - Open biopsy of the left scalene lymph nodes has been utilized to identify distant spread of cervical carcinoma in selected groups of patients who do not have other clinical evidence of disseminated disease. Twenty-one patients with primary cervical carcinoma and histologically proven para-aortic lymph node metastases and 10 patients with centrally recurrent tumors underwent scalene lymph node biopsy at Walter Reed Army Medical Center or the Naval Hospital, Bethesda, Maryland, between July 1, 1979 and June 30, 1985. All patients undergoing scalene node biopsy had clinically negative physical examinations. There were no surgical complications. All 31 biopsies were negative for metastatic tumor. Combined with previously reported data from this instituton, 3 of 28 patients (11%) with primary cervical carcinoma and involved para-aortic nodes, and 6 of 35 patients (17%) with centrally recurrent disease had subclinical scalene node metastases. Patients with clinically suspicious scalene lymphadenopathy had fine needle aspiration cytology performed to document metastatic disease. The success of this technique has eliminated the need for open biopsy in these patients. Scalene node biopsy provides valuable prognostic information in patients with cervical cancer who have positive para-aortic lymph nodes. It also obviates surgical exploration in some patients felt to have resectable recurrent disease who actually have subclinical distant spread.

UR - http://www.scopus.com/inward/record.url?scp=0023513845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023513845&partnerID=8YFLogxK

U2 - 10.1016/0090-8258(87)90178-8

DO - 10.1016/0090-8258(87)90178-8

M3 - Article

C2 - 3678980

AN - SCOPUS:0023513845

VL - 28

SP - 312

EP - 317

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -